Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Nitropyridine >  5-Bromo-2-methyl-3-nitropyridine

5-Bromo-2-methyl-3-nitropyridine

Basic information Safety Supplier Related

5-Bromo-2-methyl-3-nitropyridine Basic information

Product Name:
5-Bromo-2-methyl-3-nitropyridine
Synonyms:
  • 5-Bromo-2-methyl-3-nitropyridine
  • 5-Bromo-3-nitropicoline
  • 5-Bromo-2-methyl-3-nitrop...
  • 5-Bromo-3-nitro-2-picoline
  • 5-broMo-2-Methyl-3-n
  • Pyridine,5-broMo-2-Methyl-3-nitro-
  • 5-Bromo-2-methyl-3-nitropyridine >
  • 5-Bromo-2-methyl-3-nitropyridine ISO 9001:2015 REACH
CAS:
911434-05-4
MF:
C6H5BrN2O2
MW:
217.02
EINECS:
200-258-5
Product Categories:
  • Heterocycle-Pyridine series
Mol File:
911434-05-4.mol
More
Less

5-Bromo-2-methyl-3-nitropyridine Chemical Properties

Melting point:
38.0 to 42.0 °C
Boiling point:
253 °C
Density 
1.709
Flash point:
107 °C
storage temp. 
Inert atmosphere,Room Temperature
pka
-0.44±0.20(Predicted)
form 
powder to crystal
color 
Light yellow to Amber to Dark green
InChI
InChI=1S/C6H5BrN2O2/c1-4-6(9(10)11)2-5(7)3-8-4/h2-3H,1H3
InChIKey
FZZLWWNOYMHSIS-UHFFFAOYSA-N
SMILES
C1(C)=NC=C(Br)C=C1[N+]([O-])=O
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
HS Code 
2933399990
More
Less

5-Bromo-2-methyl-3-nitropyridine Usage And Synthesis

Uses

5-Bromo-2-methyl-3-nitropyridine is used as a reactant in the synthesis of MLN0905, a potent and orally bioavailable inhibitor of Polo-like kinase 1 (PLK1).

Synthesis

911434-04-3

911434-05-4

Step 2 - Synthesis of 5-bromo-2-methyl-3-nitropyridine Diethyl 2-(5-bromo-3-nitropyridin-2-yl)malonate (1.2 g, 3.3 mmol) was dissolved in 7.0 N HCl (10 mL). The mixture was heated to reflux for 5 hours. After completion of the reaction, it was cooled to room temperature and extracted with dichloromethane: methanol (10:1, v/v). The organic phases were combined, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was purified by column chromatography using petroleum ether: ethyl acetate (4:1, v/v) as eluent to afford 5-bromo-2-methyl-3-nitropyridine (0.7 g, yield: 89.7%). 1H-NMR (CDCl3, 400 MHz) δ 8.76 (s, 1H), 8.40 (s, 1H), 2.80 (s, 3H).

References

[1] Patent: US2008/194552, 2008, A1. Location in patent: Page/Page column 40
[2] Patent: WO2010/68292, 2010, A1. Location in patent: Page/Page column 78
[3] Patent: WO2013/33899, 2013, A1. Location in patent: Page/Page column 39
[4] Patent: WO2013/34048, 2013, A1. Location in patent: Page/Page column 46; 47
[5] Patent: WO2012/88411, 2012, A1. Location in patent: Page/Page column 64

5-Bromo-2-methyl-3-nitropyridineSupplier

Changzhou chennuo Biotechnology Co., Ltd Gold
Tel
17768395970
Email
35015765@qq.com
Shanghai Tuolei Chemical Reagents Co., Ltd.
Tel
86-021-50318510
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Alfa Aesar
Tel
400-6106006
Email
saleschina@alfa-asia.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com